Penny Stock VLRX Pops on CBD Study Results

VLRX and MNTA are two healthcare stocks to monitor today

Jul 30, 2019 at 9:47 AM
facebook twitter linkedin

One stock making a notable move this morning is Valeritas Holdings Inc (NASDAQ:VLRX), which is gaining 13.2% to trade at $2.83, thanks to news the company used its proprietary h-Patch technology to effectively deliver cannabidiol (CBD) subcutaneously. The news could help VLRX shares gain some attention on Wall Street, where right now only two analysts are in coverage -- though they're quite bullish, based on the average price target of $13.

From a broader view, Valeritas stock has done nothing but slide on the charts this year after trading above $30 in late 2018, sporting a year-to-date deficit of more than 60% through last night's close. Even with today's gains, the shares are sitting below the 50-day moving average that has acted as resistance in recent months.

Another healthcare name making moves today is Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). The Food and Drug Administration (FDA) granted the company's treatment for hemolytic disease of the fetus and newborn (HDFN) fast track designation. This news has the shares up 2.2% at $10.87, as they try to battle back from their three-year low of $9.51 from last week. Year-over-year, MNTA as given back 63%.

There's a notable setup in the options pits, too, even though Momenta sees light volume on an absolute basis. Still, the Schaeffer's put/call open interest ratio (SOIR) of 2.41 ranks in the 98th annual percentile, showing that those who have speculated on MNTA with short-term contracts are unusually put-heavy at the moment.



Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

Best stocks for October and worst stocks for October


Special Offers from Schaeffer's Trading Partners